Treatment approaches for the inflammatory manifestations of VEXAS syndrome have included broad-acting corticosteroids, as well as specific inhibitors of IL-1, IL-6, and JAK/STAT signaling (4, 5). Here, IL1B is linked to VEXAS syndrome.